Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 16,560 shares at $468.32 ($7.8M) on 2026-01-15, disclosed to the SEC on 2026-01-15.
Seasonal sale ($7.8M) by EVP & GENERAL COUNSEL — this insider has traded UTHR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $468.32 | 1,439 | $674K | 8.7% |
| 2 | $468.32 | 1,439 | $674K | 8.7% |
| 3 | $469.34 | 3,531 | $1.7M | 21.3% |
| 4 | $469.34 | 3,531 | $1.7M | 21.3% |
| 5 | $470.37 | 1,307 | $615K | 7.9% |
| 6 | $470.37 | 1,307 |
| $615K |
| 7.9% |
| 7 | $471.44 | 1,576 | $743K | 9.5% |
| 8 | $471.44 | 1,576 | $743K | 9.5% |
| 9 | $472.28 | 407 | $192K | 2.5% |
| 10 | $472.28 | 407 | $192K | 2.5% |
| 11 | $474.74 | 40 | $19K | 0.2% |
| Total | $469.88 avg | 16,560 | $7.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |